Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase b that unites the pathways of coagulation and fibrinolysis

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Mosnier, Laurent
  • Bouma, B. N.

publication date

  • November 2006

journal

  • Arteriosclerosis, Thrombosis, and Vascular Biology  Journal

abstract

  • The coagulation and fibrinolytic systems safeguard the patency of the vasculature and surrounding tissue. Cross regulation of coagulation and fibrinolysis plays an important role in preserving a balanced hemostatic process. Identification of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) as an inhibitor of fibrinolysis and one of the main intermediates between coagulation and fibrinolysis, greatly improved our understanding of cross regulation of coagulation and fibrinolysis. As TAFI is an enzyme that is activated by thrombin generated by the coagulation system, its activation is sensitive to the dynamics of the coagulation system. Defects in coagulation, such as in thrombosis or hemophilia, resonate in TAFI-mediated regulation of fibrinolysis and imply that clinical symptoms of coagulation defects are amplified by unbalanced fibrinolysis. Thrombomodulin promotes the generation of both antithrombotic activated protein C (APC) and prothrombotic (antifibrinolytic) activated TAFI, illustrating the paradoxical effects of thrombomodulin on the regulation of coagulation and fibrinolysis. This review will discuss the role of TAFI in the regulation of fibrinolysis and detail its regulation of activation and its potential therapeutic applications in thrombotic disease and bleeding disorders.

subject areas

  • Animals
  • Antifibrinolytic Agents
  • Blood Coagulation
  • Carboxypeptidase B
  • Carboxypeptidase B2
  • Enzyme Stability
  • Fibrinolysis
  • Genetic Engineering
  • Genetic Variation
  • Hemophilia A
  • Humans
  • Thrombin
  • Thrombolytic Therapy
  • Thrombomodulin
scroll to property group menus

Research

keywords

  • APC
  • TAFI
  • carboxypeptidase B
  • coagulation
  • fibrinolysis
  • hemophilia
  • thrombomodulin
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1079-5642

Digital Object Identifier (DOI)

  • 10.1161/01.ATV.0000244680.14653.9a

PubMed ID

  • 16960106
scroll to property group menus

Additional Document Info

start page

  • 2445

end page

  • 2453

volume

  • 26

issue

  • 11

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support